{"id":721793,"date":"2026-04-15T00:20:13","date_gmt":"2026-04-14T21:20:13","guid":{"rendered":"https:\/\/buradabiliyorum.com\/en\/science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon\/"},"modified":"2026-04-15T00:20:13","modified_gmt":"2026-04-14T21:20:13","slug":"science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon\/","title":{"rendered":"Science Corp prepares first human brain sensor placement with Yale neurosurgeon"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_84 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a26ea8287452\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #dd3333;color:#dd3333\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #dd3333;color:#dd3333\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a26ea8287452\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/buradabiliyorum.com\/en\/science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon\/#The_biohybrid_gambit\" >The biohybrid gambit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/buradabiliyorum.com\/en\/science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon\/#From_eyes_to_brains\" >From eyes to brains<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/buradabiliyorum.com\/en\/science-corp-prepares-first-human-brain-sensor-placement-with-yale-neurosurgeon\/#A_crowded_field_with_different_bets\" >A crowded field with different bets<\/a><\/li><\/ul><\/nav><\/div>\n<p><img decoding=\"async\" src=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2026\/04\/science-corp-biohybrid-brain-sensor-first-human-hodak-yale.png\" \/><\/p>\n<div id=\"article-main-content\">\n<p><em><a href=\"https:\/\/buradabiliyorum.com\/en\/category\/sciencee\/\" data-internallinksmanager029f6b8e52c=\"5\" title=\"Science\" target=\"_blank\" rel=\"noopener\">Science<\/a> Corporation, the BCI company founded by ex-Neuralink president Max Hodak, is preparing to place a pea-sized, 520-electrode sensor on a human brain\u2019s surface during already-scheduled surgery. Yale neurosurgery chair Murat G\u00fcnel will lead the programme; trials could begin in 2027. The company also has PRIMA, a retinal implant that restored vision in 38 patients (NEJM-published), with CE mark <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>roval expected mid-2026. Science Corp raised $230M <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/watch-movies-tv-seriess\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Watch Movies &amp; TV Series\" target=\"_blank\" rel=\"noopener\">Series<\/a> C at a $1.5B valuation ($490M total) and employs 150 people.<\/em><\/p>\n<p>Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, is preparing to place its first sensor inside a human skull. The device, \u00a0a pea-sized chip packed with 520 recording electrodes, will not be pushed into brain tissue like Neuralink\u2019s implant. Instead, it will rest on top of the cortex, recording neural activity from the surface while a neurosurgeon is already operating for an unrelated condition. If everything goes to plan, the first placement could happen in a patient who needs brain surgery for a stroke.<\/p>\n<p>The man who will perform that surgery is Murat G\u00fcnel, chair of the Department of Neurosurgery at Yale School of Medicine and neurosurgeon-in-chief of Yale New Haven Health. Science Corp appointed G\u00fcnel as its medical director for brain-computer interfaces at the end of March, following two years of discussions with Hodak. His task is to develop the clinical and surgical programme for the company\u2019s biohybrid BCI project, starting with the first human sensor placement.<\/p>\n<p>G\u00fcnel\u2019s approach is deliberately opportunistic. Rather than recruiting patients specifically for a brain-computer interface trial, the plan is to identify people who already require significant cranial surgery, stroke victims, for instance, who need a craniectomy to relieve swelling. With the skull already open and the brain exposed, placing a small sensor on the cortical surface adds minimal additional risk and time. G\u00fcnel expects to evaluate the device\u2019s safety and its ability to record brain activity in these initial cases.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_biohybrid_gambit\"><\/span>The biohybrid gambit<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"inarticle-wrapper channel-cta\">\n<div class=\"ica-text\">\n<p class=\"ica-text__title\">TNW City Coworking space &#8211; Where your best work happens<\/p>\n<p>A workspace designed for growth, collaboration, and endless networking opportunities in the heart of tech.<\/p>\n<\/div>\n<\/div>\n<p>What makes Science Corp\u2019s <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/technology\/\" data-internallinksmanager029f6b8e52c=\"4\" title=\"Technology\" target=\"_blank\" rel=\"noopener\">technology<\/a> unusual in a field crowded with electrode arrays is what comes after the sensor. The company\u2019s long-term vision is a biohybrid neural interface: a device embedded with lab-grown neurons that are genetically modified with light-sensitive proteins. Micro-LEDs on the chip trigger those neurons to fire, and nearby recording electrodes detect the activity. The lab-grown neurons are designed to integrate naturally with the patient\u2019s own brain cells over time, forming a biological bridge between electronics and neural tissue.<\/p>\n<p>The first human placement will not include the biohybrid components. It is a recording-only device, intended to prove that the sensor can safely sit on the brain\u2019s surface and capture meaningful signals. But the architecture is built to accommodate the biological layer later, which is what distinguishes Science Corp from<span>\u00a0<\/span>every other company in the BCI space. Where Neuralink, Paradromics, and Synchron are refining how electrodes interact with neurons, Science Corp wants to grow new neurons that speak both languages, biological and electronic, natively.<\/p>\n<p>Science Corp says it does not plan to seek FDA approval for these initial sensor placements, arguing that the tiny device poses no significant risk to patients who are already undergoing major brain surgery. Instead, the company will work through institutional review boards, the ethics committees that oversee human research at academic medical centres. G\u00fcnel is already in discussions with the relevant boards, though he describes a timeline of beginning trials in 2027 as \u201coptimistic.\u201d<\/p>\n<h2><span class=\"ez-toc-section\" id=\"From_eyes_to_brains\"><\/span>From eyes to brains<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The brain sensor represents Science Corp\u2019s second front. The company\u2019s more advanced programme is PRIMA, a retinal implant designed to restore vision in patients with geographic atrophy caused by age-related macular degeneration, a leading cause of blindness. Results published in the New England Journal of Medicine in October 2025 showed that 38 patients across 17 clinical sites in five countries gained an average improvement of 25.5 letters, more than five lines on a standard eye chart, after 12 months. Eighty-four per cent of patients could read letters, numbers, and words. An accompanying NEJM editorial called PRIMA \u201cthe first treatment to restore vision\u201d in patients with advanced geographic atrophy.<\/p>\n<p>The PRIMA implant is a 2mm-by-2mm photovoltaic chip, roughly 30 micrometres thick, \u00a0half the width of a human hair, that sits beneath the retina and is powered wirelessly by specialised glasses projecting near-infrared light. It has FDA breakthrough device designation, and Science Corp has submitted a CE mark application to the European Union, expecting approval by mid-2026.<\/p>\n<p>The company closed a $230 million Series C in March 2026, led by Lightspeed, with participation from Khosla Ventures, Y Combinator, Quiet Capital, and IQT, the<span>\u00a0<\/span>strategic investment arm of the intelligence community. The round valued Science Corp at $1.5 billion, bringing total funding to $490 million. The company employs 150 people.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"A_crowded_field_with_different_bets\"><\/span>A crowded field with different bets<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Science Corp enters human brain trials as the BCI sector accelerates. Neuralink, which Hodak co-founded before leaving in 2021, has implanted its N1 device in over 20 patients and recently expanded trials to the UK, where a patient at University College London Hospital controlled a computer within hours of surgery. The company has begun planning for high-volume production and<span>\u00a0<\/span>automated surgical procedures<span>\u00a0<\/span>in 2026.<\/p>\n<p>Paradromics, which received FDA investigational device exemption approval for its Connexus system in late 2025, claims an information transfer rate exceeding 200 bits per second, \u00a0more than 20 times faster than Neuralink\u2019s initial reported performance. Its target is speech restoration for people with severe paralysis. Synchron has taken a less invasive route entirely, deploying its Stentrode device through blood vessels rather than requiring open brain surgery, with more than 50 patients implanted and a demonstration of an ALS patient controlling an iPad by thought alone.<\/p>\n<p>Each company is making a fundamentally different technical bet. Neuralink is optimising for electrode density and surgical automation. Paradromics is pursuing raw bandwidth. Synchron is trading signal quality for surgical simplicity. Science Corp is betting that biology itself, lab-grown neurons that fuse with the brain, will eventually outperform all of them.<\/p>\n<p>That bet is unproven and years from validation. The biohybrid concept has been demonstrated in laboratory settings but never in a human brain. The first sensor placement will not test the biological integration; it will test whether the hardware platform can record usable signals from the cortical surface without complication. From there, the path to a fully biohybrid interface, neurons and all, stretches through<span>\u00a0<\/span>regulatory territory<span>\u00a0<\/span>that no company has yet mapped.<\/p>\n<p>G\u00fcnel, who has spent decades operating on the brain, brings the kind of clinical credibility that a startup founded by a technologist needs. Hodak understands electrodes, optics, and genetically modified neurons. G\u00fcnel understands the organ they are asking to accept them. Whether Science Corp\u2019s biohybrid vision is a breakthrough or a detour will depend on how well those two forms of<span>\u00a0<\/span>expertise converge<span>\u00a0<\/span>in the operating room.<\/p>\n<\/p><\/div>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN63nwsw68G3Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more like this article, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/buradabiliyorum.com\/en\/category\/technology\/\" target=\"_blank\" >Technology category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/thenextweb.com\/news\/science-corp-biohybrid-brain-sensor-first-human-hodak-yale\" target=\"_blank\" >Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Science Corporation, the BCI company founded by ex-Neuralink president Max Hodak, is preparing to place a pea-sized, 520-electrode sensor on a human brain\u2019s surface during already-scheduled surgery. Yale neurosurgery chair Murat G\u00fcnel will lead the programme; trials could begin in 2027. The company also has PRIMA, a retinal implant that restored vision in 38 patients&#8230;<\/p>\n","protected":false},"author":1,"featured_media":721794,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2026\/04\/science-corp-biohybrid-brain-sensor-first-human-hodak-yale.png","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-721793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/721793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=721793"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/721793\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/721794"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=721793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=721793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=721793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}